Relapsing polychondritis (RP) 
Introduction
Relapsing polychondritis (RP) is a disease of unknown etiology and is characterized by cartilage inflammation. It was first described by Jaksch-Wartenhorst in 1923 and the term "Relapsing Polychondritis" was adopted in 1960. 1, 2 RP can be isolated or secondary to malignancy, connective tissue diseases or other autoimmune diseases. 3, 4 Neurological involvement is uncommon. Here we describe a case of RP who first presented to us because of facial palsy.
Case Report
A 60-year-old man presented with right sided facial weakness for 3 days. He had 6 month history of recurrent episodes of pain and swelling of left pinna, each episode persisted for 3-5 days and responded to non-steroidal anti-inflammatory drugs (NSAIDs). He also had episodes of mild pain in throat and nose. He complained of hearing difficulty and generalized weakness but did not have any history of arthritis, fever, night sweats or weight loss.
The patient was moderately anaemic with normal vitals. His left ear was distorted (Fig 1a) . Examination of the nervous system was normal except right sided lower motor neuron type facial nerve palsy (Fig 2) . Other examination findings were unremarkable. His haemoglobin was 8.2 gm/dl, normochromic-normocytic, total white cell count was 11,600/cmm with normal differentials, platelet count was 1,92,000/cmm, ESR 100 mm in 1 st hour and CRP 24 mg/L (less than 6). Blood film showed nonspecific morphology with mildly left shifted neutrophil leukocytosis. Urine routine examination did not show any red cell, protein or cast. Ultrasonogram of abdomen was normal as were liver and renal biochemistry including electrolytes. Rheumatoid factor, ANA and ANCAs were negative. Bone marrow findings were consistent with myelodysplastic syndrome (MDS); refractory anaemia with multilineage dysplasia (Fig 3a-d) . Audiogram revealed bilateral mixed type of hearing loss. Histopthological examination of pinna revealed degenerative change (Fig 4) .
He was finally diagnosed as a case of RP with MDS. Treatment was started with oral prednisolone at a dose of 0.5 mg/kg/day and he responded well. Neurological features may be present in up to 9% cases of RP and includes hemiplegia, cerebellar dysfunction, aseptic meningoencephalitis, polyneuritis, myelitis or cranial nerve palsy. 7 By literature search we found few cases of RP who first presented with facial palsy. [7] [8] [9] It may be debated whether facial palsy in our case was isolated Bell's palsy or not? We do believe that may it be so, but it is much more likely to be an association with RP. Another question may arise regarding absence of inflammatory cellular infiltrate of in histopathology of auricular cartilage. It is to be noted that biopsy is not mandatory for diagnosis of RP, moreover when patient agreed for biopsy there was no signs of active inflammation of pinna.
Malignancy is a common association of RP. Calistru AM et al. in a retrospective analysis of RP cases associated with Sweet syndrome found that 60% of cases were associated with malignancy or premalignant conditions and MDS was the leading cause occurring in 85% cases. 3 Recently Haque MA et al. reported a case of RP from Bangladesh. 10 But our patient was unique in that he had associated neurological features and MDS.
Treatment options for RP include corticosteroids, NSAIDs, methotrexate, hydroxychloroquine, colchicine, dapsone, salazopyrone, azathioprine and plasmapheresis in severe cases. The 5 and 10-year survival is 74% and 55% respectively. Poor prognostic factors include saddle-nose deformity, systemic vasculitis and anaemia. Airway obstruction, pneumonia and cardiovascular involvement are main causes of death.
Conclusion
RP is an uncommon entity. Physicians should have high index of suspicion in appropriate clinical scenario and care should be taken to exclude associated disease(s), if present.
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